OptiClear – DRY EYE MANAGEMENT

Lasers Therapeutic

OptiClear – DRY EYE MANAGEMENT

An innovative simultaneous contact cooling using a cold sapphire tip cools the skin during treatment for longer periods of time,
further minimizing the risk of superficial burns and resulting in more comfortable treatment for patients.

Alma brings the power of Intense Pulsed Light (IPL) to your practice with OptiClear- the dedicated light-
based solution for the treatment of Meibomian Gland Dysfunction (MGD). MGD is the leading cause of
evaporative dry eye disease (DED) which affects millions of people around the world and can leads to
chronic eye discomfort and inflammation.

 

Targeted Precision Technology

MGD is associated with inflammation of the eyelids as well as a range of symptoms that can greatly interfere with
patients’ quality of life. These include dryness, itching, irritation, soreness, eye fatigue and blurred vision.

Clinical evidence has shown that the wavelength range of 550-650 nm relieves the symptoms of MGD and provides
effective, long term relief. Using Alma’s IPL technology, OptiClear harnesses light energy from a precise, narrow
band spectrum at this targeted, therapeutic range. Gentle heating liquifies the meibum, unblocks the Meibomian
glands and improves blood flow to the area, for improved gland function and long-lasting relief.

Going Beyond IPL- with Alma’s AFTTM Technology

OptiClear uses Alma’s proprietary Advanced Fluorescence Technology (AFT), an advanced form of intense
pulsed light technology (IPL). AFT converts unused UV light that is outside the therapeutic range into the optimal
spectrum, for maximum efficiency and more effective treatment. Each pulse is delivered with uniform energy
(fluence) and controlled peak power, minimizing the risk of adverse effects and ensuring maximum safety.